Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation
about
Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Siglec-mediated regulation of immune cell function in disease.Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergistRole of siglecs and related glycan-binding proteins in immune responses and immunoregulationSpecific deletion of LDL receptor-related protein on macrophages has skewed in vivo effects on cytokine production by invariant natural killer T cells.Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.Quantifying lipid contents in enveloped virus particles with plasmonic nanoparticlesSiglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27.Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona FormationInduction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-β1 Production.Dendritic cells: a spot on sialic Acid.Cross-linkable liposomes stabilize a magnetic resonance contrast-enhancing polymeric fastener.Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.Sialic acids in cancer biology and immunity.New Human CD22/Siglec-2 Ligands with a Triazole Glycoside.Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activationDirecting neuronal signaling through cell-surface glycan engineering.Viewing Siglecs through the lens of tumor immunology.Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesDisubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas.Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses.Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy.Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1.Detection of mSiglec-E, in solution and expressed on the surface of Chinese hamster ovary cells, using sialic acid functionalised gold nanoparticles.CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.Tumor-Derived Apoptotic Vesicles: With Death They Do Part.Chemical Reactive Anchoring Lipids with Different Performance for Cell Surface Re-engineering Application.CD169 Macrophages Capture and Dendritic Cells Instruct: The Interplay of the Gatekeeper and the General of the Immune SystemComparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against MelanomaThe Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes
P2860
Q30278005-A5E38DB8-1296-4C2D-82E4-E04173D7B9E5Q34314957-7E5AEA06-9114-4B22-9DC5-3E91FFADD387Q35163983-DB474EBC-7EA8-4883-A1A8-A629040BA423Q35164415-95FDEAED-5D5F-4D3F-A8F6-02BBFC823505Q35210966-C82EEDBD-27E8-4C1E-BB20-D7F80D9DC17AQ35646486-861FB738-BC2F-4611-B8B3-A45863AADE34Q35659750-951A0906-7881-439B-A764-F39726AB9FF0Q36293523-D5DA42AE-A360-44D4-87E7-6E46347EF83BQ36828184-CCC8E891-7F48-4647-BD28-26951A9E4BF3Q37066067-8DEAE56A-F8D7-40A3-9574-CAD5D8CD84DCQ37415555-AAF8315F-6B22-48F3-B690-73FD2FB0E5F0Q37697419-9FC296CA-37EC-45CF-9122-CC5DB884C7E9Q38162231-2CC3AF37-45F9-4383-9D38-255643747A75Q38598881-5521C358-90CA-45A1-84DA-EB006D66E4EEQ38620799-D197AD6F-986D-44A5-81AC-C726AB00A125Q38709008-2F79F75D-4AC4-45D2-BBD6-597FCE13F7B5Q38977473-1992A96C-A006-47E0-A50D-18F5F899BF77Q39003003-D76F9941-5DA3-4186-9A4D-A7763444FFF0Q39160967-0EE4E765-704D-47CF-9B8B-11DE6EF8DC4DQ39448911-E06C6580-4F8D-40F3-B7AE-D4EBBF8418A8Q40415354-BDE05262-5AA5-4749-8C8C-1956F830C3F5Q40593868-FD0DD523-227F-4A87-88C8-FAFBE5B04C0FQ41139823-E38219F5-EF37-4734-8812-EAEA0CB48242Q50355298-F23AC0E5-A4A7-4800-98FE-A23E779E109DQ51564500-6B631C5E-E55C-494F-9500-F552EFF3D907Q54937363-E7B5FE23-A572-4A51-BD81-E732AC093150Q55035002-D5C84D9B-35DE-4AF8-A925-EAEC03391125Q55261866-99FE3299-6FF4-4154-A736-41DFB2FAFD91Q58707686-7E98C92F-1E55-44E5-A94D-2637FEEFD3F1Q58761430-5C548E30-9416-4A30-B01B-A75D48544BFDQ59136982-62F9FF42-84F8-4794-8036-FA5BFF60B5B1
P2860
Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Targeted delivery of lipid ant ...... tural killer T cell activation
@en
type
label
Targeted delivery of lipid ant ...... tural killer T cell activation
@en
prefLabel
Targeted delivery of lipid ant ...... tural killer T cell activation
@en
P2093
P2860
P356
P1476
Targeted delivery of lipid ant ...... tural killer T cell activation
@en
P2093
Archana Khurana
Christoph Rademacher
Corwin M Nycholat
James C Paulson
Jose Luis Vela
Norihito Kawasaki
Paul R Crocker
P2860
P304
P356
10.1073/PNAS.1219888110
P407
P577
2013-04-22T00:00:00Z